Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Constitutional and acquired dysprothrombinemias]

F Josso, J M Lavergne, J P Soulier

    Nouvelle Revue Francaise D'Hematologie
    |September 1, 1970
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Factor VIII genotype and inhibitor development in patients with haemophilia A: highest risk in patients with splice site mutations.

    Haemophilia : the official journal of the World Federation of Hemophilia·2008
    Same author

    Factor VIII (FVIII) gene mutations in 120 patients with hemophilia A: detection of 26 novel mutations and correlation with FVIII inhibitor development.

    Journal of thrombosis and haemostasis : JTH·2007
    Same author

    Identification of intron 1 and 22 inversion mutations in the factor VIII gene of 124 Iranian families with severe haemophilia A.

    Haemophilia : the official journal of the World Federation of Hemophilia·2004
    Same author

    Type 2 von Willebrand disease causing defective von Willebrand factor-dependent platelet function.

    Best practice & research. Clinical haematology·2001
    Same author

    Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen.

    Thrombosis and haemostasis·2001
    Same author

    Functional mapping of anti-factor IX inhibitors developed in patients with severe hemophilia B.

    Blood·2001